Dapabite M 5mg/500mg Tablet ER

Overview Dapabite M 5mg/500mg Tablet ER

Metformin/Dapagliflozin extended-release tablets (5mg/500mg) are a dual-action medication for managing type 2 diabetes. This combination effectively lowers elevated blood glucose, thereby mitigating the risk of severe diabetic complications and cardiovascular events. This medication can be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician and should not be altered without their guidance; discontinuation may lead to uncontrolled blood sugar, potentially resulting in kidney impairment or vision loss. This medication complements a comprehensive diabetes management plan, including dietary adjustments, regular physical activity, and weight management as prescribed by your doctor. Commonly reported side effects include headache, nausea, vomiting, diarrhea, sore throat, nasal congestion, and rhinorrhea. Adequate hydration is crucial to avoid dehydration. Genital fungal infections may occur; diligent hygiene can help minimize this risk. Prior to commencing treatment, inform your doctor of any existing kidney or liver conditions, urinary tract infections, or diuretic use. Pregnant or lactating individuals should seek medical counsel before use. Limit alcohol consumption, as it may enhance the likelihood of side effects. Regular blood glucose monitoring is essential during treatment.

Primary Ingredients of Dapabite M 5mg/500mg Tablet ER

No text provided. Please provide the text you wish me to rephrase.

Uses of Dapabite M 5mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Dapabite M 5mg/500mg Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Dapabite M 5mg/500mg Extended-Release Tablet with food.

Common Side effects of Dapabite M 5mg/500mg Tablet ER:

• Nausea
• Vomiting
• Diarrhea
• Genital fungal infection
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Urinary tract infection
• Polyuria
• Flatulence
• Skin rash
• Taste change
• Difficulty in urination
• Hypoglycemia (low blood glucose level)
• Tremors
• Dizziness
• Back pain
• Increased hematocrit
• Decreased creatinine clearance
• Dyslipidemia

How to use Dapabite M 5mg/500mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Dapabite M 5mg/500mg Extended-Release tablets with food.

How Dapabite M 5mg/500mg Tablet ER works:

The extended-release Dapabite M tablet (5mg/500mg) combines dapagliflozin and metformin, two medications that manage blood sugar. Dapagliflozin eliminates excess glucose via urinary excretion, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin sensitivity. This dual action leads to improved glycemic control.

What if you forget to take Dapabite M 5mg/500mg Tablet ER :

Should you forget a dose of Dapabite M 5mg/500mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.